Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03641664 · ClinicalTrials.gov registry record · NA
FCT Study: Reducing the Need for Out-of-Home Placements
A NA study of Mental Disorder and Behavior Problem, sponsored by Duke University.
- Active
- Registry status
- NA
- Development phase
- 750
- Enrollment target
- 2
- Study locations
NCT03641664: Active NA study of Mental Disorder and Behavior Problem, sponsored by Duke University.
NCT03641664 is a NA study of Mental Disorder and Behavior Problem that is active but no longer recruiting, run by Duke University. The registered enrollment target is 750 participants, above the 289-participant average among 21 other Mental Disorder trials with a reported enrollment target (160% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03641664, a NA study of Mental Disorder and Behavior Problem, is active but no longer recruiting, sponsored by Duke University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 750 participants
- Enrollment target
- 2
- Study locations
Study Summary
Does Family Centered Treatment (FCT) result in better youth, family, and cost outcomes, as compared to a Level II or Level III out-of-home placement (OHP)? The investigators test the hypotheses that among children/youth authorized to a Level II or Level III out-of-home placement, relative to youth who receive such a placement, those who receive FCT will have: * Better: family functioning and mental/behavioral health outcomes (youth and caregiver). * Lower probability of: being subject of a child protective services report, entering (or re-entering) foster care, being arrested, being retained in grade, being chronically absent (missing \>15 days), dropping out of high school, or receiving an out-of-home placement. * Lower cost of care.
Primary Outcome
The Family Assessment Device will be used to measure overall level of family functioning. This subscale ranges from 1 to 4. Higher scores indicate a worse outcome. Both overall functioning and change in functioning will be assessed.
Conditions Studied
Interventions
- BEHAVIORAL Family Centered Treatment
- BEHAVIORAL Level II or Level III Out of Home Placement
Study Locations (2)
North Carolina
- Cardinal Innovations Health Care - Charlotte
- Partners Behavioral Health Management - Elkin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2018-09-10 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What the registry record for NCT03641664 still lists
NCT03641664 is an interventional study that assigns participants to a tested intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap, above the 289-participant average among 21 other Mental Disorder trials with a reported enrollment target (160% higher).
The record links to 3 conditions, with Mental Disorder appearing as the primary indexed condition, and to 2 interventions - of which Family Centered Treatment is the first listed.
NCT03641664 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03641664 about?
NCT03641664 is a clinical study titled "FCT Study: Reducing the Need for Out-of-Home Placements". Does Family Centered Treatment (FCT) result in better youth, family, and cost outcomes, as compared to a Level II or Level III out-of-home placement (OHP)? The investigators test the hypotheses that among children/youth authorized to a Level II or Level III out-of-home placement, relative to youth ...
What is the current status of trial NCT03641664?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 750 participants. The study started on 2018-09-10. Estimated completion is 2027-06-30.
What conditions does trial NCT03641664 study?
This clinical trial studies the following conditions: Mental Disorder, Behavior Problem, Emotional Problem.
What interventions are being tested in trial NCT03641664?
The interventions under investigation include: Family Centered Treatment (BEHAVIORAL), Level II or Level III Out of Home Placement (BEHAVIORAL).
Who is sponsoring clinical trial NCT03641664?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03641664 being conducted?
This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mental Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03641664's enrollment target sits among peer trials
750 3rd of 21 higher than 19 of 21 other Mental Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mental Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ACT for HIV-Positive Men
RECRUITING · NA
-
Healthy ReStart Intervention to Improve Health and Functioning
RECRUITING · NA
-
Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis Use
RECRUITING · NA
-
Enhancing Immune Health Randomized Controlled Trial
RECRUITING · NA
-
Transdiagnostic Behavior Therapy Vs TAU for Adjustment Disorder Following Traumatic Event Exposure
RECRUITING · NA
-
Brain Stimulation to the Hippocampus in Schizophrenia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI